Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. BGB-10188

   BEONE MEDICINES AUS PTY LTD

   Chronic Lymphocytic Leukemia

   phase 2 · small molecule · completed

   1 trial →

2. BGB-11417

   BEONE MEDICINES AUS PTY LTD

   Acute Myeloid Leukemia

   phase 2 · small molecule · active

   1 trial →

3. BGB-11417

   BEONE MEDICINES AUS PTY LTD

   Leukemia

   phase 2 · small molecule · active

   1 trial →

4. BGB-11417-103

   BEONE MEDICINES AUS PTY LTD

   Myeloid malignancies (acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN.

   phase 2 · small molecule · active

   1 trial →

5. BGB-11417-108

   BEONE MEDICINES AUS PTY LTD

   previously untreated chronic lymphocytic leukemia (CLL)

   phase 2 · small molecule · active

   1 trial →

6. BGB-11417-204

   BEONE MEDICINES AUS PTY LTD

   Previously Untreated Chronic Lymphocytic Leukemia

   phase 2 · small molecule · active

   1 trial →

7. BGB-A317

   The First People's Hospital of Lianyungang

   Gastric Cancer

   phase 2 · small molecule · completed

   1 trial →

8. BGB-A445

   BEONE MEDICINES AUS PTY LTD

   Urothelial Carcinoma

   phase 2 · small molecule · active

   1 trial →

9. BGJ398 (infigratinib)

   BridgeBio Oncology Therapeutics

   Advanced Cholangiocarcinoma

   phase 2 · small molecule · terminated

   1 trial →

10. BI-754091 plus afatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma (ESCC)

    phase 2 · small molecule · completed

    1 trial →

11. BL-B01D1

    Sichuan Baili Pharmaceutical Co.,

    Cervical Cancer

    phase 2 · small molecule · active

    1 trial →

12. BL-B01D1

    Sichuan Baili Pharmaceutical Co.,

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

13. BL0020

    Shanghai Best-Link Bioscience

    Small Cell Carcinoma of Lung

    phase 2 · small molecule · active

    1 trial →

14. BLEOMYCIN

    Fondazione Telethon ETS

    colorectal cancer

    phase 2 · small molecule · active

    1 trial →

15. BLEOMYCIN, CISPLATIN

    Fondazione Telethon ETS

    patients with newly diagnosed or recurrent high-grade or initially invasive precancerous squamous lesions of the vulva and non-invasive vulvar Paget's disease

    phase 2 · small molecule · active

    1 trial →

16. BLEOPRIM for CARCINOMA OF THE ORAL CAVITY AN…

    Fondazione Telethon ETS

    CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX

    phase 2 · small molecule · active

    1 trial →

17. BLEOPRIM for Locally Advanced Pancreatic Can…

    Fondazione Telethon ETS

    Locally Advanced Pancreatic Cancer

    phase 2 · small molecule · active

    1 trial →

18. BLU-285-3101

    Blueprint Medicines (Netherlands) B.V.

    Solid Tumors Dependent on KIT or PDGFRA Signaling

    phase 2 · small molecule · active

    1 trial →

19. BMS-986466

    Bristol-Myers Squibb

    Advanced Solid Tumors

    phase 2 · small molecule · terminated

    1 trial →

20. BMS-986504

    Bristol-Myers Squibb

    Solid Tumors

    phase 2 · small molecule · active

    1 trial →

21. BMS-986517

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumors

    phase 2 · small molecule · active

    1 trial →

22. BMS-986523, BMS-986523

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumor Malignancies

    phase 2 · small molecule · active

    1 trial →

23. BNT111

    Regeneron UK Limited

    Melanoma Stage III

    phase 2 · mab · completed

    1 trial →

24. BNT111-01

    BioNTech SE

    Melanoma (Stage III and IV)

    phase 2 · small molecule · active

    1 trial →

25. BNT116

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

26. BNT142

    BioNTech SE

    Solid Tumors

    phase 2 · small molecule · active

    1 trial →

27. BNT314-02

    BioNTech SE

    Metastatic colorectal cancer

    phase 2 · small molecule · active

    1 trial →

28. BNT321-02

    BioNTech SE

    Resected (R0 or R1) pancreatic ductal adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

29. BNT326-01

    BioNTech SE

    Advanced solid tumors

    phase 2 · small molecule · active

    1 trial →

30. BNT326-02

    BioNTech SE

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

31. BNT327, BNT323

    BioNTech SE

    Advanced Breast Cancer Metastatic Breast Cancer

    phase 2 · small molecule · active

    1 trial →

32. BNT327, BNT324

    BioNTech SE

    Advanced Lung Cancer

    phase 2 · small molecule · active

    1 trial →

33. BNT327, DOCETAXEL

    BioNTech SE

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

34. BNT329

    BioNTech SE

    Advanced Solid Cancers

    phase 2 · small molecule · active

    1 trial →

35. BO25430

    Hoffmann-La Roche

    Metastatic Cancer

    phase 2 · small molecule · active

    1 trial →

36. BO39610

    Hoffmann-La Roche

    Metastatic non-small cell lung cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

37. BO41932

    Hoffmann-La Roche

    Solid tumors

    phase 2 · small molecule · active

    1 trial →

38. BO42533

    Hoffmann-La Roche

    Squamous cell carcinoma of the head and neck (SCCHN)

    phase 2 · small molecule · active

    1 trial →

39. BO43249

    Hoffmann-La Roche

    Resectable Stage I-III Non-Small Cell Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

40. BO43936

    Hoffmann-La Roche

    Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

    phase 2 · other · active

    1 trial →

41. BO44157

    Hoffmann-La Roche

    Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

    phase 2 · small molecule · active

    1 trial →

42. BO44178

    Hoffmann-La Roche

    Previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC)

    phase 2 · other · active

    1 trial →

43. BO44426

    Hoffmann-La Roche

    Untreated Advanced or Metastatic Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

44. BO45853

    Hoffmann-La Roche

    Early-Stage, PIK3CA-Mutated Breast Cancer (BC)

    phase 2 · small molecule · active

    1 trial →

45. BP41072

    Hoffmann-La Roche

    Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma (r/r B-cell NHL)

    phase 2 · small molecule · active

    1 trial →

46. BP42772

    Hoffmann-La Roche

    Advanced or metastatic squamous cell carcinoma of the esophagus

    phase 2 · other · active

    1 trial →

47. BP45381

    Hoffmann-La Roche

    BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)

    phase 2 · small molecule · active

    1 trial →

48. BPF-CCRT (run-in)

    Hospital Authority, Hong Kong

    Stage III Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions